Table 1

Characteristics of patients at baseline

Qualitative variable - N (%)

NNRTI group

N = 671

NRTI group

N = 225

P


Gender [Male]

536 (79.9%)

182 (80.9%)

0.7429

Risk factor for HIV acquisition

0.6749

IVDU

148 (22.1%)

46 (20.4%)

Homo-bisexual

198 (29.5%)

65 (28.4%)

Heterosexual

254 (37.9%)

83 (36.9%)

Other

16 (2.4%)

9 (4%)

Unknown

55 (8.2%)

22 (9.8%)

Nationality

0.6511

Europe or North America

608 (90.6%)

208 (92.4%)

Other

41

12

Unknown

22

5

HCV-Ab

0.8498

Positive

169 (25.2%)

55 (24.5%)

Negative

432 (64.4%)

149 (66.2%)

Unknown

70 (10.4%)

21 (9.3%)

CDC '93 Class C

200 (29.8%)

64 (28.4%)

0.6982

CD4+ classes

0.0782

≥ 200/mm3

342 (51.0%)

93 (41.3%)

201-350/mm3

146 (21.8%)

56 (24.9%)

351-500/mm3

101 (15.0%)

45 (20.0%)

> 500/mm3

82 (12.2%)

31 (13.8%)

Centre

0.1448

Master

399 (59.5%)

115 (51.1%)

Chelsea & Westminster

97 (14.5%)

38 (16.9%)

ICONA

139 (20.7%)

60 (26.7%)

HSR+Modena

35 (5.3%)

12 (5.3%)

Calendar year at study initiation

0.0137

1997-2000

264 (39.3%)

70 (31.1%)

2001-2003

309 (46.1%)

129 (57.3%)

2004-2006

98 (14.6%)

26 (11.6%)

Boosted-PI as first line

78 (11.6%)

30 (13.3%)

0.4957

Quantitative variables

Mean (SD) age [years]

39 (35-45)

38 (34-44)

0.3680

Mean (SD) pre-treatment HIV-RNA [log10 copies/ml]

5.012 (4.415-5.430)

5.000 (4.511-5.519)

0.6269

Median (IQR) CD4-count [cells/mm3]

196 (86-377)

249 (103-403)

0.0234


Torti et al. BMC Infectious Diseases 2011 11:23   doi:10.1186/1471-2334-11-23

Open Data